Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models
Crossref DOI link: https://doi.org/10.1007/s13555-017-0176-3
Published Online: 2017-02-27
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Thibaut de Ménonville, Séverine
Rosignoli, Carine
Soares, Estelle
Roquet, Manon
Bertino, Béatrice
Chappuis, Jean-Paul
Defoin-Platel/Chaussade, Claire
Piwnica, David
Funding for this research was provided by:
Nestle Skin Health
